Lobbying firm
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2018 | LANNETT COMPANY, INC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$45,000 | — | |
| 2018 | CONSCIOUS DISCIPLINE |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$37,500 | — | |
| 2018 | DR. REDDY'S LABORATORIES, LTD |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$45,000 | — | |
| 2018 | DYNAVAX TECHNOLOGIES |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$45,000 | — | |
| 2018 | STATE MUTUAL INSURANCE COMPANY |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination |
— | — | |
| 2018 | LANNETT COMPANY, INC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$45,000 | — | |
| 2018 | CONSCIOUS DISCIPLINE |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$37,500 | — | |
| 2018 | DR. REDDY'S LABORATORIES, LTD |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$45,000 | — | |
| 2018 | DYNAVAX TECHNOLOGIES |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$45,000 | — | |
| 2018 | ALBANY MOLECULAR RESEARCH INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination |
$10,000 | — |
| Client | Filings | Total Income |
|---|---|---|
| DYNAVAX TECHNOLOGIES | 65 | $2,690,000 |
| DR. REDDY'S LABORATORIES, LTD | 48 | $2,316,000 |
| TEVA PHARMACEUTICALS USA | 46 | $4,485,000 |
| GILEAD SCIENCES | 31 | $1,550,000 |
| WATSON PHARMACEUTICALS INC | 29 | $2,542,000 |
| CONSCIOUS DISCIPLINE | 28 | $1,142,500 |
| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 27 | $740,000 |
| ASCENDIS PHARMA, INC. | 26 | $1,420,000 |
| LANNETT COMPANY, INC | 24 | $1,094,174 |
| OFFICE OF GOVERNOR NATHAN DEAL | 24 | $1,006,250 |
| HYPOPARATHYROIDISM ASSOCIATION | 23 | — |
| AVET PHARMACEUTICALS | 22 | $560,000 |
| STATE MUTUAL INSURANCE COMPANY | 21 | $500,000 |
| COLLEGE OF AMERICAN PATHOLOGISTS | 21 | $310,000 |
| ALLIANCE TO PREVENT THE ABUSE OF MEDICINES | 18 | $900,000 |
| INSMED INCORPORATED | 17 | $315,000 |
| OSMOTICA PHARMACEUTICALS | 14 | $435,000 |
| AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS | 12 | $260,000 |
| IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS | 10 | $405,000 |
| CRINETICS PHARMACEUTICALS | 10 | $380,000 |
| Name | Disclosed Prior Position |
|---|---|
| WILLIAM BURKE | N/A |
| KATHY KULKARNI | N/A |
| TODD SMITH |